If you or a loved one has been diagnosed with Fabry disease, the PERIDOT (Patient ExpeRIence in Fabry Disease On VenglustaT) study may be an option. This clinical research study is seeking adults with Fabry disease to investigate the effect of a new investigational oral drug on nerve pain and abdominal pain.

To be eligible for this study, you must:

  • Be at least 18 years old
  • Have a previous confirmed diagnosis of Fabry disease
  • Have nerve pain or abdominal pain related to Fabry disease
  • Have either never received Fabry disease treatment or have not received treatment within the last six months.

Both males and females are eligible for this study. Additional criteria will be assessed to determine eligibility.

To learn more about the PERIDOT study and find out if you may be eligible, visit clinicaltrials.gov.